May, 2025

article thumbnail

Opinion: I’m a dentist from India. The fluoride debate in the U.S. horrifies me

STAT

Florida has just banned fluoride in public water , becoming the second state to do so. It’s part of decadeslong battle that has heated up in recent years. Local governments debate whether it belongs in the water supply. Parents question safety. Pseudoscience clouds public perception. Often, the conversation is framed as a domestic ideological battle between personal liberty and public health mandates.

363
363
article thumbnail

A new CFO tasked with taking ‘scrappy’ Editas from last year’s layoffs into new gene editing territory

PharmaVoice

Amy Parison, who stepped into the lead financial role at the company in March, is managing Editas Medicine’s transition to a new gene editing platform while recovering from a major overhaul.

173
173
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AviadoBio opens UK trial for FTD gene therapy

Pharma Times

Aspire-FTD study aims to stop disease progression with one-time treatment

130
130
article thumbnail

A bespoke CRISPR therapy suggests a blueprint for treating ‘N-of-1’ diseases

BioPharma Dive

A gene editing drug custom-made for a critically ill baby showed that, for some ultra-rare diseases, it’s possible to design and test a new CRISPR medicine in just a few months.

122
122
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Sanofi and CD&R finalise Opella deal, launching global consumer healthcare giant

Pharmafile

Sanofi and Clayton, Dubilier & Rice (CD&R) have officially closed the sale of a controlling 50% stake in Opella, Sanofis consumer healthcare division, positioning Opella as a new independent leader in the global consumer health space. The deal brings Sanofi approximately 10bn in net cash proceeds. Sanofi retains a 48.2% share in Opella, with Bpifrance […] The post Sanofi and CD&R finalise Opella deal, launching global consumer healthcare giant appeared first on Pharmafile.

100
100
article thumbnail

Accretion Pharmaceuticals’ IPO to open on May 14 2025; Price band fixed at ₹96-101

Express Pharma

Accretion Pharmaceuticals, an Ahmedabad-headquartered pharmaceuticals manufacturer, announced that its initial public offering (IPO) will open for subscription on Wednesday, May 14, 2025. The anchor portion will be opened on Tuesday, May 13, 2025, and the issue will conclude on Friday, May 16, 2025. The company intends to raise 29.75 crore from the offering and aims to be listed on the NSE Emerge platform.

More Trending

article thumbnail

FDA awards cancer drug approvals to AbbVie and MSD

Pharmaceutical Technology

The FDA has approved MSDs Welireg for rare adrenal tumours, and AbbVies Emrelis for treating c-Met+ lung cancer patients.

110
110
article thumbnail

Pharmacies voted most accessible healthcare location

The Pharmacist

Community pharmacy was the most accessible healthcare location for the public last winter, ahead of general practice, dentists and hospital services, polling by YouGov has found. Almost six in 10 people who tried to access community pharmacies last winter found it easy to do so, compared to just four in 10 who could easily access […] The post Pharmacies voted most accessible healthcare location appeared first on The Pharmacist.

article thumbnail

FDA sets stricter approval standards for COVID vaccines

BioPharma Dive

The agency will now require randomized, controlled data before approving new COVID shots for healthy children and adults, Commissioner Martin Makary and top vaccine official Vinay Prasad wrote in NEJM.

article thumbnail

Duck Creek Technologies appoints Tyler Jones as chief marketing officer

Pharmafile

Duck Creek Technologies has appointed Tyler Jones as its new chief marketing officer (CMO). He will lead the companys global marketing strategy, supporting its position as a provider of property and casualty (P&C) insurance software. Jones brings more than two decades of experience at the intersection of insurance, technology and customer experience.

94
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Cadila Pharmaceuticals launches Empadon (Empagliflozin)

Express Pharma

Cadila Pharmaceuticals has launched Empadon (Empagliflozin), marking its foray into the transformative SGLT2 inhibitor therapy space. The SGLT2 inhibitor class, with Empagliflozin at its forefront, has emerged as a cornerstone in the management of Type 2 Diabetes Mellitus (T2DM), Cardiovascular Disease (CVD), and Chronic Kidney Disease (CKD). With the recent expiry of Empagliflozins patent, the landscape is ripe for expanding access to this game-changing therapy.

article thumbnail

Opinion: I was a Theranos whistleblower. Here’s what I think Elizabeth Holmes is up to

STAT

I always knew Elizabeth Holmes would have a second act. But I’m shocked it’s starting while she’s still behind bars. Elizabeth is now serving an 11-year sentence for defrauding investors in Theranos and has been banned from participating in federal health programs. The company was built on her claim that, at 19 years old, she had invented a device capable of running hundreds of tests from just a single drop of blood.

358
358
article thumbnail

Sanofi pledges a $20 billion investment programme in the US

pharmaphorum

Sanofi is the latest European pharma group to promise a big capital investment programme on manufacturing and R&D in the US

86
article thumbnail

What will hub and spoke changes mean for independents?

The Pharmacist

From October, new legislation will enable pharmacies across separate legal entities to take advantage of hub and spoke dispensing, pending parliamentary approval. NHS England modelling has previously suggested that hub and spoke dispensing will increase 2% each year, freeing up workforce capacity to deliver more clinical services. But some sector leaders have raised concerns about […] The post What will hub and spoke changes mean for independents?

80
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

FDA delays approval decision for Biohaven rare disease drug

BioPharma Dive

Shares of the biotech fell around 15% on news the FDA is not only taking longer to review the drug, but will assemble an outside group of advisers to evaluate it as well.

98
article thumbnail

EMCrit 1:1 Nursing 001 – An Easy Case of Sepsis

EMCrit Project

Our first episode uses a simple case to act as touch-point for a discussion of resus nursing in the ED. EMCrit Project by Scott Weingart, MD FCCM.

86
article thumbnail

Lupin gains USFDA nod for Raltegravir Tablets USP, 600 mg

Express Pharma

Lupin announced that it has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Raltegravir Tablets USP, 600 mg. Raltegravir Tablets are bioequivalent to Isentress HD Tablets, 600 mg of Merck Sharp & Dohme. Lupin is the exclusive first-to-file for this product and is eligible for 180 days of generic drug exclusivity.

102
102
article thumbnail

Sedative ‘dex’ is replacing ‘tranq’ in illegal drug supply and causing excruciating withdrawal

STAT

The era of “tranq” may be ending. But tranq, as the powerful veterinary tranquilizer xylazine is known in the illicit drug supply, is being replaced at least in part by a dangerous new sedative: medetomidine. In the past year, the anesthetic has become an increasingly common element in the drug supply, with cities and states including Philadelphia, Pittsburgh, Chicago, and San Francisco reporting cases of medetomidine-involved overdoses.

324
324
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Next‑Gen Pharma: AI, ML & Digital Twins Converge at AUTOMA+ 2025

Pharmaceutical Technology

The 5th Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) will gather industry leaders in Vsendorf, Austria on 24-25 November for indepth case studies, practical workshops and highimpact networking designed to accelerate pharmas digital journey.

86
article thumbnail

Prescribing Red Flags: Pharmacists Be Wary of What the Doctor Orders

FDA Law Blog: Biosimilars

By Larry K. Houck Last month the U.S. Attorneys Office for the Northern District of Illinois announced that Walgreens agreed to pay up to $350,000,000 to resolve allegations that its pharmacies illegally filled millions of invalid prescriptions for opioids and other controlled substances in violation of the federal Controlled Substances Act, and sought payment for filling many of those prescriptions by federal health care programs, violating the False Claims Act.

article thumbnail

Prasad’s FDA appointment pressures cell and gene therapy stocks

BioPharma Dive

A vocal opponent of his predecessor Peter Marks, Vinay Prasad will now lead the office tasked with reviewing some genetic medicines, adding more uncertainty to an already struggling field of research.

83
article thumbnail

Putting in the Work: How to Take Back Control of Your Career Development

The Script

Want to grow your pharmacy career? Learn how to take charge through continuous learning, networking, mentorship, and goal settingwith support from Rx relief.

96
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

UnitedHealth CEO Chris Witty steps down

pharmaphorum

Andrew Witty has resigned as CEO of US health conglomerate UnitedHealth, as the company pulled its financial forecasts for 2025

78
article thumbnail

STAT+: Scientific societies call for a moratorium on using CRISPR to create genetically modified children

STAT

Leading trade organizations representing the makers of cell and gene therapies are calling for a 10-year international moratorium on the use of CRISPR and other DNA-editing tools to create genetically modified children, according to a draft of the declaration provided to STAT.  The move — coming more than seven years after Chinese researcher He Jiankui announced the birth of the world’s first CRISPR babies — is intended to send a clear signal to the global scientific co

358
358
article thumbnail

WeightWatchers scraps business model to team up with anti-obesity drugs provider

The Guardian - Pharmaceutical Industry

Brand shifts away from dieting towards weight-loss injections after filing for bankruptcy in the US WeightWatchers is teaming up with a provider of weight-loss drugs such as Wegovy and Mounjaro, in a seismic shift for the brand away from a focus on dieting as it tries to turn around its struggling business. WeightWatchers, which has promoted a non-medical, points-based approach to food intake since its creation in the 1960s , has announced a strategic partnership in the UK with CheqUp, a provide

68
article thumbnail

Patent box tax incentives pharmaceutical innovation

Drug Patent Watch

"The Patent Box Tax Incentive: A Game-Changer for Pharmaceutical Innovation? As the pharmaceutical industry continues to drive groundbreaking research and development, a lesser-known tax incentive has emerged as a key catalyst for innovation. The Patent Box tax regime, introduced in the UK in 2013, has been hailed as a success in fostering a culture of R&D and entrepreneurship.

74
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

How counterfeiters are breaching India’s QR code system

Express Pharma

There is growing concern that a sizable proportion of medicines in India could be unsafe for patients. For example, on April 19, 2025, CDSCO published three lists of Not of Standard Quality (NSQ) drug alerts for March 2025, spanning 131 product batches. The most common reason cited is failing the dissolution test as per IP 2022. In the recent past, pharma associations as well as many individual pharma companies have clarified the differences between various terms: spurious, NSQ and counterfeits,

article thumbnail

Delivering NHS pharmacy services 'could pay for a new staff member'

The Pharmacist

Delivering nationally-commissioned NHS pharmacy services could generate enough income to pay the wages of an additional staff member, Community Pharmacy North East London chief executive has suggested. Delivering just 20 NHS consultations each week could generate as much as 451.70, Shilpa Shah told contractors this week at the Sigma 2025 conference in Baku, Azerbaijan.

article thumbnail

Digital player Hinge Health rises sharply after NYSE debut

pharmaphorum

In a signal of a return to investor appetite for digital health stocks, Hinge Health has raised an impressive $437 million in an IPO

59
article thumbnail

Bill Gates to accelerate spending at his foundation — then wind it down

STAT

Philanthropist Bill Gates announced Thursday that he will wind down his massive charity in 20 years, doubling spending over that time to accelerate the work it hopes to achieve. Gates made the announcement on the 25th anniversary of the launch of the Gates Foundation, the third-largest player in international philanthropy. He said the foundation would spend $200 billion between now and 2045, when its operations will wind down.

327
327
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.